The long-term functional outcomes in our studies suggest this is likely the case, and at minimum demonstrate that PD-1/PD-L1 binding on blood monocytes can improve early outcomes without compromising long-term recovery, making peripheral PD-1 activation an intriguing approach to limit inflammatory injury after large territory stroke. Here, PDCD1 is linked to Stroke.